These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 22025886)

  • 1. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.
    Reeder SB; Cruite I; Hamilton G; Sirlin CB
    J Magn Reson Imaging; 2011 Oct; 34(4):729-749. PubMed ID: 22025886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.
    Ligabue G; Besutti G; Scaglioni R; Stentarelli C; Guaraldi G
    Quant Imaging Med Surg; 2013 Aug; 3(4):192-5. PubMed ID: 24040614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat Quantification in the Abdomen.
    Hong CW; Fazeli Dehkordy S; Hooker JC; Hamilton G; Sirlin CB
    Top Magn Reson Imaging; 2017 Dec; 26(6):221-227. PubMed ID: 29176468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
    Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.
    Park J; Lee JM; Lee G; Jeon SK; Joo I
    Korean J Radiol; 2022 Jan; 23(1):13-29. PubMed ID: 34983091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fat quantification: where do we stand?
    Starekova J; Reeder SB
    Abdom Radiol (NY); 2020 Nov; 45(11):3386-3399. PubMed ID: 33025153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease.
    Sim KC; Kim MJ; Cho Y; Kim HJ; Park BJ; Sung DJ; Han NY; Han YE; Kim TH; Lee YJ
    J Korean Med Sci; 2022 Dec; 37(49):e339. PubMed ID: 36536543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.
    Jang W; Song JS
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.
    Kramer H; Pickhardt PJ; Kliewer MA; Hernando D; Chen GH; Zagzebski JA; Reeder SB
    AJR Am J Roentgenol; 2017 Jan; 208(1):92-100. PubMed ID: 27726414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
    Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
    J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
    Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
    World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fat content determined by magnetic resonance imaging and spectroscopy.
    Springer F; Machann J; Claussen CD; Schick F; Schwenzer NF
    World J Gastroenterol; 2010 Apr; 16(13):1560-6. PubMed ID: 20355234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive means of measuring hepatic fat content.
    Mehta SR; Thomas EL; Bell JD; Johnston DG; Taylor-Robinson SD
    World J Gastroenterol; 2008 Jun; 14(22):3476-83. PubMed ID: 18567074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.
    Patel NS; Peterson MR; Brenner DA; Heba E; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2013 Mar; 37(6):630-9. PubMed ID: 23383649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.
    Tamaki N; Ajmera V; Loomba R
    Nat Rev Endocrinol; 2022 Jan; 18(1):55-66. PubMed ID: 34815553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
    Tang A; Tan J; Sun M; Hamilton G; Bydder M; Wolfson T; Gamst AC; Middleton M; Brunt EM; Loomba R; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2013 May; 267(2):422-31. PubMed ID: 23382291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.
    Zhang YN; Fowler KJ; Hamilton G; Cui JY; Sy EZ; Balanay M; Hooker JC; Szeverenyi N; Sirlin CB
    Br J Radiol; 2018 Sep; 91(1089):20170959. PubMed ID: 29722568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.